Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Based on the extracted page content, New Age Ventures is not a SaaS product or enterprise software platform, but a global venture studio/investment firm. It positions itself as an investor in “bold founders,” focusing on startups from pre-seed to Series B, with actively managed investments across healthcare, medical devices, digital health, clean technology, consumer technology, deep tech, applied AI, and related sectors.
Its core value lies not in software functionality, but in capital and entrepreneurial support. The text emphasizes evaluating founder/market fit, domain expertise, and clarity of vision, while also expressing a willingness to build genuine long-term partnerships with founders throughout the company lifecycle. The listed portfolio companies are largely concentrated in medical devices, cognitive health, cardiovascular care, treatment for female pelvic floor disorders, and other healthcare-related areas, suggesting a strong preference for hard tech and healthtech.
Using common enterprise software evaluation criteria, the available content does not disclose core feature modules, package pricing, free trials, third-party integrations, team collaboration permissions, data security and compliance, deployment methods, or API/developer support. As such, it should not be evaluated as a SaaS product, and it is not possible to assess software-related factors such as value for money, ease of use, or customer support. If users are looking for enterprise tools, the information on this site does not match that need.
The main advantages are that its investment coverage spans from pre-seed to Series B and that it covers a relatively broad range of sectors. It also emphasizes providing additional resources to strong teams, which may indicate not only funding but also long-term hands-on support. The drawbacks are that public information is relatively limited: it does not specify investment size, terms, application process, geographic preferences, team background, or details of post-investment resources. For Chinese founders, the page content also does not make clear the communication channels, legal structure, or convenience of cross-border investment.
New Age Ventures is better suited to early-stage and growth-stage startup teams seeking funding, post-investment resources, or venture studio collaboration, especially in healthcare, deep tech, and applied AI. It is not suitable for business users looking to purchase SaaS or enterprise software. The page does not provide information on access from China, so actual testing would be required; payment issues are also not applicable. If the goal is fundraising, it may be worth comparing it with other early-stage VCs, industry funds, accelerators, or investment firms focused on medical technology.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on newageventures.net official site.
newageventures.net is an United States SaaS provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach newageventures.net directly.